Sort
39,280 grants matching “leukemia”
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia
$383,193Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2020 · CA
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
$383,156Markus Mãschen · Yale University · R01 · FY2021 · CA
Elucidating the AKT-dependent and AKT-independent mechanisms of metabolic control by mTORC2
$383,156David A Guertin · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · CA
Mechanisms of Nural Crest Cell Development
$383,115Ching-Pin Chang · Stanford University · R01 · FY2010 · HL
T cell plasticity, fusion proteins and CAR T cell-based immunotherapy of head and neck cancer
$383,100Xinhui Wang · Massachusetts General Hospital · R01 · FY2022 · DE
The role of the PAFc subunit Cdc73 in normal hematopoiesis and transformation
$383,066Andrew George Muntean · University Of Michigan At Ann Arbor · R01 · FY2019 · HL
Notch Signaling in Alloimmunity
$383,034Ivan Maillard · University Of Michigan At Ann Arbor · R01 · FY2012 · AI
PATHOGENESIS OF NOTCH 1 LEUKEMIA
$383,017Brigham And Women'S Hospital · R01 · FY2000 · CA
Regulation of GLI1, a synthetic lethal target of SMARCA4-deficiency, in lung adenocarcinoma
$383,011James Kim · Ut Southwestern Medical Center · R01 · FY2023 · CA
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
$383,007Michael A. Farrar · University Of Minnesota · R01 · FY2020 · CA
Understanding T Cell Rapamycin Resistance
$383,001Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Combination Gene Therapy and Th1Th2 Therapy
$383,001Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Activation and inactivation of VH gene recombination
$382,985Ranjan Sen · National Institute On Aging · ZIA · FY2012 · AG
Validating the eCyPA/CD147 signaling complex for myeloma therapy
$382,977Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Southwest Oncology Group
$382,959Patrick J Stiff · Loyola University Chicago · U10 · FY2008 · CA
Mechanisms of Neural Crest Cell Development
$382,941Ching-Pin Chang · Stanford University · R01 · FY2009 · HL
MLL Function in the Maintenance of the Blood Forming System
$382,918Patricia A Ernst · University Of Colorado Denver · R01 · FY2015 · HL
Targeting antigen presentation to enhance GVL responses after Bone Marrow Transpl
$382,918Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2015 · HL
The role of the PAFc subunit Cdc73 in normal hematopoiesis and transformation
$382,858Andrew George Muntean · University Of Michigan At Ann Arbor · R01 · FY2020 · HL
SUMO-dependent Regulation of Ubiquitin Ligases in Genomic Stability
$382,790Michael Nicholas Boddy · Scripps Research Institute, The · R01 · FY2016 · GM
SUMO-dependent Regulation of Ubiquitin Ligases in Genomic Stability
$382,790Michael Nicholas Boddy · Scripps Research Institute, The · R01 · FY2015 · GM
Mechanisms of Neural Crest Cell Development
$382,781Ching-Pin Chang · Stanford University · R01 · FY2008 · HL
CCR5 inhibitors to enhance therapeutic response of breast cancer to DNA damaging agents
$382,756Richard G Pestell · Baruch S. Blumberg Institute · R21 · FY2020 · CA
KDM5 histone lysine demethylases as potential novel myeloid tumor suppressors
$382,745Julie-Aurore Losman · Dana-Farber Cancer Inst · R01 · FY2020 · CA
KDM5 histone lysine demethylases as potential novel myeloid tumor suppressors
$382,745Julie-Aurore Losman · Dana-Farber Cancer Inst · R01 · FY2018 · CA